Development code · Small Molecule
AEF-0117
AEF-0117 is a development code for AEF0117 (lixosicone), developed by Aelis Farma S.A..
- Status
- Phase 2 for Cannabis use disorder
- Mechanism
- CB1 NAM
- Developer
- Aelis Farma S.A.
Programs
- AEF0117 (lixosicone) for Cannabis use disorderPhase 2Active
Also known as
- AEF0117
- lixosicone
- 3beta-(4-methoxybenzyloxy)pregn-5-en-20-one
- 1610878-71-1